A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
About the study
IMPAHCT: Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial is a Phase 2b/Phase 3 study to evaluate the safety and efficacy of AV-101 (dry powder inhaled imatinib) in patients with Pulmonary Arterial Hypertension (PAH). The Phase 2b part of the study will assess three doses to establish an optimal dose for the Phase 3 part of the study. The Phase 2b primary endpoint will be the placebo corrected change in pulmonary vascular resistance (PVR). The Phase 3 primary endpoint will be the placebo corrected change in 6-minute walk distance (6MWD) after 24 weeks of treatment.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Key Inclusion Criteria
* PAH belonging to one of the subgroups:
- I/HPAH, PAH-CTD,
- PAH due to drugs and/or toxins/chemicals (having been in the care of the investigator for at least one year with no relapses of drug or toxin/chemical abuse),
- HIV associated or
- PAH due to repaired congenital heart disease (at least 1 year since repair)
- World Health Organization (WHO) Functional Class II, III or IV symptoms
- Stable concomitant background therapy of at least one PAH approved medications
- Able to walk a distance of at least 100 m but no more than 475 m during the Screening 6-minute walk tests.
EXCLUSION CRITERIA
Key Exclusion Criteria
- Pulmonary hypertension (PH) belonging to Groups 2 to 5
- A history of left-sided heart disease
- Pregnant or breast-feeding females
Additional criteria may apply, per protocol
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study Details
Contition
Pulmonary Arterial Hypertension
Age (in years)
18 - 75
Phase
PHASE2/PHASE3
Participants Needed
202
Est. Completion Date
Aug 9, 2024
Treatment Type
INTERVENTIONAL
Sponsor
Aerovate Therapeutics
ClinicalTrials.gov NCT Identifier
NCT05036135
Study Number
AV-101-002
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?